{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:13:35Z","timestamp":1784121215583,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,2,17]],"date-time":"2007-02-17T00:00:00Z","timestamp":1171670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,2,17]],"date-time":"2007-02-17T00:00:00Z","timestamp":1171670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s10067-006-0528-3","type":"journal-article","created":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T13:45:03Z","timestamp":1171633503000},"page":"1459-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Mattheus K.","family":"Reinders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N.","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieternella M.","family":"Houtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus R. B. J.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim L. Th. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,17]]},"reference":[{"key":"528_CR1","first-page":"651","volume":"22","author":"TL Jansen","year":"2004","unstructured":"Jansen TL, Reinders MK, van Roon EN et al (2004) Benzbromarone withdrawn from the European market: another case of \u201cabsence of evidence is evidence of absence\u201d? Clin Exp Rheumatol 22:651","journal-title":"Clin Exp Rheumatol"},{"key":"528_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(94)80011-1","volume":"20","author":"MM Van der Klauw","year":"1994","unstructured":"Van der Klauw MM, Houtman PM, Stricker BH et al (1994) Hepatic injury caused by benzbromarone. J Hepatol 20:376\u2013379","journal-title":"J Hepatol"},{"key":"528_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S0168-8278(00)80263-9","volume":"32","author":"H Wagayama","year":"2000","unstructured":"Wagayama H, Shiraki K, Sugimoto K et al (2000) Fatal fulminant hepatic failure associated with benzbromarone. J Hepatol 32:874","journal-title":"J Hepatol"},{"key":"528_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1440-1746.2002.02692.x","volume":"17","author":"M Arai","year":"2002","unstructured":"Arai M, Yokosuka O, Fujiwara K et al (2002) Fulminant hepatic failure associated with benzbromarone treatment: a case report. J Gastroenterol Hepatol 17:625\u2013626","journal-title":"J Gastroenterol Hepatol"},{"key":"528_CR5","first-page":"701","volume":"59","author":"A Masbernard","year":"1981","unstructured":"Masbernard A, Giudicelli CP (1981) Ten years\u2019 experience with benzbromarone in the management of gout and hyperuricaemia. S Afr Med J 59:701\u2013706","journal-title":"S Afr Med J"},{"key":"528_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/rheumatology\/kel071","volume":"45","author":"S Sutaria","year":"2006","unstructured":"Sutaria S, Katbamna R, Underwood M (2006) Effectiveness of interventions for the treatment of acute and prevention of recurrent gout\u2014a systematic review. Rheumatology 45:1422\u20131431","journal-title":"Rheumatology"},{"key":"528_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"KH Choi","year":"2005","unstructured":"Choi KH, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143:499\u2013516","journal-title":"Ann Intern Med"},{"key":"528_CR8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMcp030733","volume":"349","author":"RA Terkeltaub","year":"2003","unstructured":"Terkeltaub RA (2003) Gout. N Engl Med J 349:1647\u20131655","journal-title":"N Engl Med J"},{"key":"528_CR9","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1001\/jama.289.21.2857","volume":"289","author":"KT Rott","year":"2003","unstructured":"Rott KT, Agudelo CA (2003) Gout. JAMA 289:2857\u20132860","journal-title":"JAMA"},{"key":"528_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.bor.0000162060.25895.a5","volume":"17","author":"RL Wortmann","year":"2005","unstructured":"Wortmann RL (2005) Recent advances in the management of gout and hyperuricemia. Curr Opin Rheumatol 17:319\u2013324","journal-title":"Curr Opin Rheumatol"},{"key":"528_CR11","first-page":"577","volume":"28","author":"J Li-Yu","year":"2001","unstructured":"Li-Yu J, Clayburne G, Sieck M et al (2001) Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 28:577\u2013580","journal-title":"J Rheumatol"},{"key":"528_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"A Shoji","year":"2004","unstructured":"Shoji A, Yamanaka H, Kamatani N (2004) A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51:321\u2013325","journal-title":"Arthritis Rheum"},{"key":"528_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-5381-6_3","volume":"431","author":"H Yamanaka","year":"1998","unstructured":"Yamanaka H, Togashi R, Hakoda M et al (1998) Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment. Adv Exp Med Biol 431:13\u201318","journal-title":"Adv Exp Med Biol"},{"key":"528_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/art.10511","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Pijoan JI et al (2002) Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 47:356\u2013360","journal-title":"Arthritis Rheum"},{"key":"528_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/ard.57.9.545","volume":"57","author":"F Perez-Ruiz","year":"1998","unstructured":"Perez-Ruiz F, Alonso-Ruiz A, Calabozo M et al (1998) Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis 57:545\u2013549","journal-title":"Ann Rheum Dis"},{"key":"528_CR16","first-page":"S40","volume":"85","author":"P Hanvivadhanakul","year":"2002","unstructured":"Hanvivadhanakul P, Akkasilpa S, Deesomchok U (2002) Efficacy of benzbromarone compared to allopurinol in lowering serum urate level in hyperuricemic patients. J Med Assoc Thai 85:S40\u2013S47","journal-title":"J Med Assoc Thai"},{"key":"528_CR17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","volume":"131","author":"E Pascual","year":"1999","unstructured":"Pascual E, Batlle-Gualda E, Martinez A et al (1999) Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 131:756\u2013759","journal-title":"Ann Intern Med"},{"key":"528_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT et al (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895\u2013900","journal-title":"Arthritis Rheum"},{"key":"528_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/bmj.38975.390370.7C","volume":"333","author":"J Traynor","year":"2006","unstructured":"Traynor J, Mactier R, Geddes CC et al (2006) How to measure renal function in clinical practice. BMJ 333:733\u2013737","journal-title":"BMJ"},{"key":"528_CR20","first-page":"A0828","volume":"11","author":"AS Levey","year":"2000","unstructured":"Levey AS, Greene T, Kusek JW et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:A0828","journal-title":"J Am Soc Nephrol"},{"key":"528_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0002-9343(90)90097-W","volume":"89","author":"WD Kaehny","year":"1990","unstructured":"Kaehny WD, Tangel DJ, Johnson AM et al (1990) Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates. Am J Med 89:49\u201352","journal-title":"Am J Med"},{"key":"528_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","volume":"76","author":"KR Hande","year":"1984","unstructured":"Hande KR, Noone RM, Stone WJ (1984) Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 76:47\u201356","journal-title":"Am J Med"},{"key":"528_CR23","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR Jr, Wortmann RL et al (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353:2450\u20132461","journal-title":"N Engl J Med"},{"key":"528_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","volume":"12","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Patel PA, Schumacher HR et al (2006) Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 12:61\u201365","journal-title":"J Clin Rheumatol"},{"key":"528_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Erauskin GG et al (2002) Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum 47:610\u2013613","journal-title":"Arthritis Rheum"},{"key":"528_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.50.9.631","volume":"50","author":"T Yamamoto","year":"1991","unstructured":"Yamamoto T, Moriwaki Y, Takahashi S et al (1991) Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol. Ann Rheum Dis 50:631\u2013633","journal-title":"Ann Rheum Dis"},{"key":"528_CR27","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","volume":"64","author":"N Schlesinger","year":"2004","unstructured":"Schlesinger N (2004) Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 64:2399\u20132416","journal-title":"Drugs"},{"key":"528_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/ard.62.6.572","volume":"62","author":"S Takahashi","year":"2003","unstructured":"Takahashi S, Moriwaki Y, Yamamoto T et al (2003) Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and\/or losartan on urate metabolism. Ann Rheum Dis 62:572\u2013575","journal-title":"Ann Rheum Dis"},{"key":"528_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ndt\/gfh629","volume":"20","author":"B Vogt","year":"2005","unstructured":"Vogt B (2005) Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol Dial Transplant 20:431\u2013433","journal-title":"Nephrol Dial Transplant"},{"key":"528_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10067-005-0043-y","volume":"25","author":"JD Moolenburgh","year":"2006","unstructured":"Moolenburgh JD, Reinders MK, Jansen TL (2006) Rasburicase treatment in severe tophaceous gout; a novel therapeutic option. Clin Rheumatol 25:749\u2013752","journal-title":"Clin Rheumatol"},{"key":"528_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11926-001-0048-8","volume":"3","author":"AG Fam","year":"2001","unstructured":"Fam AG (2001) Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient. Curr Rheumatol Rep 3:29\u201335","journal-title":"Curr Rheumatol Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-006-0528-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0528-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T19:22:30Z","timestamp":1709320950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-006-0528-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,17]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0528-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,17]]},"assertion":[{"value":"2 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}